# TAZAROTENE
> **ANDA213079** · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS ISRAEL · Approved 2023-04-25
## Drug
- **FDA Application Number:** ANDA213079
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TAZAROTENE
- **Generic name:** TAZAROTENE
- **Active ingredients:** TAZAROTENE
- **Dosage form:** GEL
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** PADAGIS ISRAEL
- **Manufacturer:** Padagis Israel Pharmaceuticals Ltd
- **First approval:** 2023-04-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213079)
---
*AI Analytics · CC0 1.0*